col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


39 Results       Page 1

 [1] 
Wiley: Angewandte Chemie International Edition
  original article Date Title Authors   All Authors
1 [GO] 2022―May―12 Amplification-Free Detection of SARS-CoV-2 and Respiratory Syncytial Virus Using CRISPR Cas13a and Graphene Field-Effect Transistors Huijie Li, Jie Yang, Guangfu Wu, Zhengyan Weng, Yang Song, Yuxuan Zhang, et al. (+8)
2 [GO] 2022―May―04 Towards Control and Oversight of SARS-CoV-2 Diagnosis and Monitoring through Multiplexed Quantitative Electroanalytical Immune Response Biosensors. Rebeca M. Torrente-Rodríguez, Ana Montero-Calle, Clara San Bartolomé, Olga Cano, Monica Vazquez, María Iglesias-Caballero, et al. (+7)
3 [GO] 2022―Feb―22 The SARS-CoV-2 Spike Glycoprotein Directly Binds Exogeneous Sialic Acids:  A NMR View Luca Unione, Maria J Moure, Maria Pia Lenza, Iker Oyenarte, June Ereño-Orbea, Ana Ardá, Jesus Jimenez-Barbero
4 [GO] 2022―Jan―19 Inhibition of ACE2-Spike interaction by an ACE2 binder suppresses SARS-CoV-2 entry Young-Hee Shin, Kiyoung Jeong, Jihye Lee, Hyo Jung Lee, Junhyeong Yim, Jonghoon Kim, et al. (+2)
5 [GO] 2021―Dec―22 A Charge-Switchable Zwitterionic Peptide for Rapid Detection of SARS-CoV-2 Main Protease Zhicheng Jin, Yash Mantri, Maurice Retout, Yong Cheng, Jiajing Zhou, Alec Jorns, et al. (+12)
6 [GO] 2021―Dec―10 A Dual-Color Fluorescent Probe Allows Simultaneous Imaging of Main and Papain-like Proteases of SARS-CoV-2-Infected Cells for Accurate Detection and Rapid Inhibitor Screening Jesse Jokerst, Yong Cheng, Raina M. Borum, Alex E. Clark, Zhicheng Jin, Colman Moore, et al. (+3)
7 [GO] 2021―Sep―28 Inhibition Mechanism of SARS-CoV-2 Main Protease with Ketone-Based Inhibitors Unveiled by Multiscale Simulations. Insights for Improved Designs Carlos A. Ramos-Guzmán, J. Javier Ruiz-Pernía, Iñaki Tunón
8 [GO] 2021―Sep―27 NMR spectroscopy of the main protease of SARS-CoV-2 and fragment-based screening identify three protein hotspots and an antiviral fragment François-Xavier Cantrelle, Emmanuelle Boll, Lucile Brier, Danai Moschidi, Sandrine Belouzard, Valérie Landry, et al. (+7)
9 [GO] 2021―Sep―21 Repurposing an Antiviral Drug against SARS-CoV-2 Main Protease Arighna Sarkar, Kalyaneswar Mandal
10 [GO] 2021―Sep―20 Frontispiece: Efficient Inhibition of SARS-CoV-2 Using Chimeric Antisense Oligonucleotides through RNase L Activation Xiaoxuan Su, Wenxiao Ma, Di Feng, Boyang Cheng, Qian Wang, Zefeng Guo, et al. (+2)
11 [GO] 2021―Sep―17 A SARS-CoV-2 Neutralization Assay using Single Molecule Arrays Tal Gilboa, Limor Cohen, Chi-An Cheng, Roey Lazarovits, Augusta Uwamanzu-Nna, Isaac Han, et al. (+7)
12 [GO] 2021―Aug―31 High Affinity Dimeric Aptamers Enable Rapid Electrochemical Detection of Wild-Type and B.1.1.7 SARS-CoV-2 in Unprocessed Saliva Zijie Zhang, Richa Pandey, Jiuxing Li, Jimmy Gu, Dawn White, Hannah D. Stacey, et al. (+12)
13 [GO] 2021―Jul―30 Discovery and characterization of spike N-terminal domain-binding aptamers for rapid SARS-CoV-2 detection Nataly Kacherovsky, Lucy F. Yang, Ha V. Dang, Emmeline L. Cheng, Ian I. Cardle, Alexandra C. Walls, et al. (+7)
14 [GO] 2021―Jul―19 Corrigendum: Sterilizing Immunity against SARS-CoV-2 Infection in Mice by a Single-Shot and Lipid Amphiphile Imidazoquinoline TLR7/8 Agonist-Adjuvanted Recombinant Spike Protein Vaccine Sonia Jangra, Jana De Vrieze, Angela Choi, Raveen Rathnasinghe, Gabriel Laghlali, Annemiek Uvyn, et al. (+16)
15 [GO] 2021―Jul―19 Corrigendum: Re I Tricarbonyl Complexes as Coordinate Covalent Inhibitors for the SARS-CoV-2 Main Cysteine Protease Johannes Karges, Mark Kalaj, Milan Gembicky, Seth M. Cohen
16 [GO] 2021―Jul―19 Efficient Inhibition of SARS-CoV-2 Using Chimeric oligonucleotides through RNase L Activation Xiaoxuan Su, Wenxiao Ma, Di Feng, Boyang Cheng, Qian Wang, Zefeng Guo, et al. (+2)
17 [GO] 2021―Jun―23 Exploring the druggability of conserved RNA regulatory elements in the SARS-CoV-2 genome Sridhar Sreeramulu, Christian Richter, Hannes Berg, Maria A Wirtz Martin, Betül Ceylan, Tobias Matzel, et al. (+31)
18 [GO] 2021―May―27 Infrared based saliva screening test for COVID-19 Bayden Robert Wood, Kamila Kochan, Diana E. Bedolla, Natalia Salazar-Quiroz, Samantha Grimley, David Perez-Guaita, et al. (+17)
19 [GO] 2021―Apr―29 Supramolecular cylinders target bulge structures in the 5' UTR of the RNA genome of SARS-CoV-2 and inhibit viral replication Lazaros Melidis, Harriet Hill, Nicholas Coltman, Scott Davies, Kinga Winczura, Tasha Chauhan, et al. (+9)
20 [GO] 2021―Apr―26 Synthetic Homogeneous Glycoforms of the SARS-CoV-2 Spike Receptor-Binding Domain Reveals Different Binding Profiles of Monoclonal Antibodies Farong Ye, Jie Zhao, Peng Xu, Xinliang Liu, Jing Yu, Wei Shangguan, et al. (+7)
21 [GO] 2021―Apr―16 Polysulfates block SARS-CoV-2 uptake via electrostatic interactions Chuanxiong Nie, Paria Pouyan, Daniel Lauster, Jakob Trimpert, Yannic Kerkhoff, Gergo Peter Szekeres, et al. (+9)
22 [GO] 2021―Mar―30 Aptamer Blocking Strategy Inhibits SARS-CoV-2 Virus Infection Miao Sun, Siwen Liu, Xinyu Wei, Shuang Wan, Mengjiao Huang, Ting Song, et al. (+6)
23 [GO] 2021―Mar―16 Frontispiece: Molecular Simulations suggest Vitamins, Retinoids and Steroids as Ligands of the Free Fatty Acid Pocket of the SARS-CoV-2 Spike Protein Deborah K. Shoemark, Charlotte K. Colenso, Christine Toelzer, Kapil Gupta, Richard B. Sessions, Andrew D. Davidson, et al. (+4)
24 [GO] 2021―Mar―12 Synthetic Homogeneous Glycoforms of the SARS-CoV-2 Spike Receptor-Binding Domain Reveals Different Binding Profiles of Monoclonal Antibodies Ping Wang, Farong Ye, Jie Zhao, Peng Xu, Xinliang Liu, Jing Yu, et al. (+7)
25 [GO] 2021―Mar―08 Magnetization transfer to enhance NOE cross-peaks among labile protons: Applications to imino-imino sequential walks in SARS-CoV-2-derived RNAs Mihajlo Novakovic, Eriks Kupce, Tali Scherf, Andreas Oxenfarth, Robbin Schnieders, Tassilo Grün, et al. (+4)
26 [GO] 2021―Mar―08 A SARS-CoV-2 spike binding DNA aptamer that inhibits pseudovirus infection by an RBD independent mechanism Günter Mayer, Anton Schmitz, Anna Weber, Mehtap Bayin, Stefan Breuers, Volkmar Fieberg, Michael Famulok
27 [GO] 2021―Mar―03 Targeting the Main Protease of SARS-CoV-2: From the Establishment of High Throughput Screening to the Design of Tailored Inhibitors Julian Breidenbach, Carina Lemke, Thanigaimalai Pillaiyar, Laura Schäkel, Ghazl Al Hamwi, Miriam Diett, et al. (+14)
28 [GO] 2021―Feb―19 Re(I) Tricarbonyl Complexes as Coordinate Covalent Inhibitors for the SARS-CoV-2 Main Cysteine Protease Johannes Karges, Mark Kalaj, Milan Bembicky, Seth Mason Cohen
29 [GO] 2021―Feb―10 Aptamer Blocking Strategy Inhibits SARS-CoV-2 Virus Infection Miao Sun, Siwen Liu, Xinyu Wei, Shuang Wan, Mengjiao Huang, Ting Song, et al. (+6)
30 [GO] 2021―Jan―20 Molecular Simulations suggest Vitamins, Retinoids and Steroids as Ligands of the Free Fatty Acid Pocket of the SARS-CoV-2 Spike Protein Deborah Karen Shoemark, Charlotte K. Colenso, Christine Toelzer, Kapil Gupta, Richard B. Sessions, Andrew D. Davidson, et al. (+4)
31 [GO] 2021―Jan―19 Sterilizing Immunity against SARS-CoV-2 Infection in Mice by a Single-Shot and Lipid Amphiphile Imidazoquinoline TLR7/8 Agonist-Adjuvanted Recombinant Spike Protein Vaccine Sonia Jangra, Jana De Vrieze, Angela Choi, Raveen Rathnasinghe, Gabriel Laghlali, Annemiek Uvyn, et al. (+16)
32 [GO] 2020―Dec―22 A ligand selection strategy identifies chemical probes targeting the proteases of SARS-CoV-2 Lilian Peñalver, Philipp Schmid, Dávid Szamosvári, Stefan Schildknecht, Christoph Globisch, Kevin Sawade, et al. (+2)
33 [GO] 2020―Dec―10 Simultaneous dual-gene diagnosis of SARS-CoV-2 based on CRISPR/Cas9-mediated lateral flow assay Erhu Xiong, Ling Jiang, Tian Tian, Menglu Hu, Huahua Yue, Mengqi Huang, et al. (+4)
34 [GO] 2020―Sep―17 Targeting RNA G-quadruplex in SARS-CoV-2: A Promising Therapeutic Target for COVID-19? Xiaogang Qu, Chuanqi Zhao, Geng Qin, Jingsheng Niu, Zhao Wang, Chunyu Wang, Jinsong Ren
35 [GO] 2020―Sep―14 Structural characterization of the N-linked glycans in the receptor binding domain of the SARS-CoV-2 spike protein and their interactions with human lectins using NMR spectroscopy Maria Pia Lenza, Iker Oyenarte, Tammo Diercks, Jon Imanol Quintana, Ana Gimeno, Alexandre Bosch, et al. (+13)
36 [GO] 2020―Aug―26 Allosteric inhibition of the SARS-CoV-2 main protease - insights from mass spectrometry-based assays Carol V Robinson, Tarick J. El-Baba, Corinne A. Lutomski, Anastassia L. Kantsadi, Tika R. Malla, Tobias John, et al. (+5)
37 [GO] 2020―Jul―30 Molecular Insights into Small Molecule Drug Discovery for SARS-CoV-2 Haibin Su, Hailei Su, Feng Zhou, Ziru Huang, Xiaohua Ma, Kathiresan Natarajan, et al. (+2)
38 [GO] 2020―Jul―14 Current status of COVID-19 (pre)clinical vaccine development Bruno de Geest, Tingting Ye, Zifu Zhong, Adolfo García-Sastre, Michael Schotsaert
39 [GO] 2020―Apr―24 Thoughts on What Chemists Can Contribute to Fighting SARS-CoV-2 - A Short Note on Hand Sanitizers, Drug Candidates and Outreach Clemens Richert, Till Opatz, Joerg Senn-Bilfinger
 [1] 

39 Results       Page 1



[de][en]

Last change 2022―Feb―03 17:06:14 UTC

© Daten-Quadrat 2022       Done in 0.009 sec